Clinical Research About Lu-xian-chang-xiong-tang On Treatment Of Vertigo (Type Of Tan-zhuo-zhong-zu And Yu-xue-zu-qiao) For Posterior Circulation Ischemic

Objective:Observe lu-xian-chang-xiong-tang in the treatment of type of Tan-zhuo-zhong-zu and Yu-xue-zu-qiao for posterior circulation ischemic about the Clinical of effect and Hemodynamic.Methods:According to the standard, dividing62patients who come from Hunan University of Traditional Chinese Medicine in a randomized, into two parts.32cases is treatment group (lu-xian-chang-xiong-tang+Mesylate Betahistine tablets) and30cases into the control group (Mesylate Betahistine tablets), after28days than observe the degree of vertigo, Syndrome of TCM, Blood flow of TCD. In order to know clinical efficacy.Results: ΦThe treatment group is better than the control group in Syndrome of TCM (p<0.01), Blood flow of TCD (Vmp〈0.01, PIp<0.05), have significant difference. it means that lu-xian-chang-xiong-tang+Mesylate Betahistine tablets is superior to separate use Mesylate Betahistine tablets.②After treatment, two groups are all better than before in degree of vertigo assessed by Europe vertigo scale (p<0.01).③During clinical observation, the control group Appear one cases of discomfort in stomach, but it can relieve itself, not use special treatment, and others have no obvious adverse reactions.Conclusion:lu-xian-chang-xiong-tang could improve symptoms of PCI and have a significant in in Syndrome of TCM, Blood flow of TCD, It shows that the Traditional Chinese Medicine with Western medicine can enhance Clinical Efficacy, reduce side effects of western medicine.